グルタミン酸の消化管粘膜保護薬としての可能性

DOI Web Site Web Site PubMed 被引用文献1件 参考文献20件
  • 天ヶ瀬 紀久子
    京都薬科大学病態薬科学系薬物治療学分野
  • 中村 英志
    味の素株式会社イノベーション研究所
  • 加藤 伸一
    京都薬科大学病態薬科学系薬物治療学分野
  • 竹内 孝治
    京都薬科大学病態薬科学系薬物治療学分野 京都消化器疾患リサーチセンター

書誌事項

タイトル別名
  • Glutamate as a Potential Protective Drug in the Gastrointestinal Mucosa
  • Symposium Review グルタミン酸の消化管粘膜保護薬としての可能性
  • Symposium Review グルタミンサン ノ ショウカカン ネンマク ホゴヤク ト シテ ノ カノウセイ

この論文をさがす

抄録

  Monosodium glutamate (MSG) is known to provide the umami taste in the food. We have recently reported that glutamate has the potential to protect the small intestine against non-steroidal anti-inflammatory drugs (NSAIDs)-induced lesions in rats. In this paper, we examined this protective effect using sodium loxoprofen, one of the NSAIDs frequently used in Asian countries, to determine whether MSG accelerates the healing of loxoprofen-induced small intestinal lesions in rats. Loxoprofen at 60 mg/kg caused hemorrhagic lesions in the small intestine, mainly in the jejunum and ileum. These lesions spontaneously healed within 7 days, but this healing process was delayed by repeated administration of loxoprofen at low doses (10, 30 mg/kg) for 5 d after lesion induction. The healing-impairment action of loxoprofen was accompanied by the down-regulation of vascular endothelium-derived growth factor (VEGF) expression and an angiogenic response. The impaired healing caused by loxoprofen was significantly restored by co-treatment with a diet containing 5% MSG for 5 d, accompanied by the enhancement of VEGF expression and angiogenesis. We suggest that daily intake of MSG not only protects the small intestine against NSAIDs-induced damage but also exerts healing-promoting effects on these lesions.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 135 (6), 779-782, 2015-06-01

    公益社団法人 日本薬学会

被引用文献 (1)*注記

もっと見る

参考文献 (20)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ